Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-16-142899)

Filing Details

Accession Number:: 0001209191-16-142899
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-09-27 16:12:36
Reporting Period:: 2016-09-23

Filing Date:: 2016-09-27
Accepted Time:: 2016-09-27 16:12:36
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1077183	Neogenomics Inc	NEO	Services-Testing Laboratories (8734)	742897368

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1591950	Maher Albitar	12701 Commonwealth Drive Suite 9 Fort Myers FL 33913	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-09-23	2,800	$8.40	60,692	No	4	S	Indirect	Shares owned by Albitar Oncology Defined Benefit Plan

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Shares owned by Albitar Oncology Defined Benefit Plan

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	63,492	Indirect	Shares owned by Albitar Oncology Defined Benefit Plan

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy)	$7.15	2017-04-20	2021-04-20	200,000	200,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2021-04-20	200,000	200,000	Direct

Footnotes

On April 20, 2016, Dr. Albitar was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.